The prevalence of antibodies to SARS-CoV-2 among blood donors in China

In this study, we investigate the seroprevalence of SARS-CoV-2 antibodies among blood donors in the cities of Wuhan, Shenzhen, and Shijiazhuang in China. From January to April 2020, 38,144 healthy blood donors in the three cities were tested for total antibody against SARS-CoV-2 followed by pseudoty...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 12; no. 1; pp. 1383 - 10
Main Authors Chang, Le, Hou, Wangheng, Zhao, Lei, Zhang, Yali, Wang, Yanbin, Wu, Linfeng, Xu, Tingting, Wang, Lilin, Wang, Juan, Ma, Jian, Wang, Lan, Zhao, Junpeng, Xu, Jing, Dong, Juan, Yan, Ying, Yang, Ru, Li, Yu, Guo, Fei, Cheng, Wenjuan, Su, Yingying, Zeng, Jinfeng, Han, Wei, Cheng, Tong, Zhang, Jun, Yuan, Quan, Xia, Ningshao, Wang, Lunan
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 02.03.2021
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In this study, we investigate the seroprevalence of SARS-CoV-2 antibodies among blood donors in the cities of Wuhan, Shenzhen, and Shijiazhuang in China. From January to April 2020, 38,144 healthy blood donors in the three cities were tested for total antibody against SARS-CoV-2 followed by pseudotype SARS-CoV-2 neutralization tests, IgG, and IgM antibody testing. Finally, a total of 398 donors were confirmed positive. The age- and sex-standardized SARS-CoV-2 seroprevalence among 18–60 year-old adults (18–65 year-old in Shenzhen) was 2.66% (95% CI: 2.24%–3.07%) in Wuhan, 0.033% (95% CI: 0.0029%–0.267%) in Shenzhen, and 0.0028% (95% CI: 0.0001%–0.158%) in Shijiazhuang, respectively. Female sex and older-age were identified to be independent risk factors for SARS-CoV-2 seropositivity among blood donors in Wuhan. As most of the population of China remained uninfected during the early wave of the COVID-19 pandemic, effective public health measures are still certainly required to block viral spread before a vaccine is widely available. Here, the authors determine seroprevalence of antibodies to SARS-CoV-2 in healthy blood donors in the cities of Wuhan, Shenzhen, and Shijiazhuang in China between January and April 2020. The age- and sex-standardized SARS-CoV-2 seroprevalence among 18–60 year-old adults is, with 2.66%, the highest in Wuhan.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2041-1723
2041-1723
DOI:10.1038/s41467-021-21503-x